Sign in to continue:

Wednesday, January 28th, 2026

Centurion, King Wan, and Singapore Market Highlights: Key Stock Moves, Fund Flows & Dividend Dates (October 2025)

Broker Name: Lim & Tan Securities
Date of Report: 15 October 2025

Excerpt from Lim & Tan Securities report.

Report Summary

  • Singapore’s FSSTI Index closed at 4,354.5, up 15% year-to-date, with mixed performances across global indices and commodities.
  • Centurion Corp acquired a central London site to develop a ~225-bed Purpose-Built Student Accommodation (PBSA), marking its entry into London and further expansion of its UK portfolio; the property is strategically located near major universities.
  • The acquisition follows Centurion’s successful spin-off of its accommodation REIT and signals its active redeployment of capital into growth assets, with the London PBSA being its second EPIISOD-branded property after Sydney.
  • Centurion Corp is viewed as undervalued post-REIT spin-off, with a consensus target price offering 42% potential upside; the broker upgrades its recommendation to “Accumulate.”
  • King Wan announced the disposal of its 30% stake in Gold Hyacinth Development, allowing it to recover investments from a loss-making associate and improve working capital; the company is also monetizing other non-core assets.
  • King Wan’s core earnings have lagged peers but are expected to improve as legacy low-margin contracts taper off and new higher-margin projects are executed; the broker sees the stock as undervalued and positive on its outlook.
  • Sector fund flows show institutional investors were net buyers in the latest week, especially in financial and industrial stocks, while retail investors were net sellers.
  • The report also highlights ongoing innovation in China’s biotechnology sector, with China catching up to the US in numbers of novel drug candidates and regulatory recognition.
  • Includes recent share transactions, upcoming dividend and earnings dates, and a list of SGX watch-list companies.

Above is an excerpt from a report by Lim & Tan Securities. Clients of Lim & Tan Securities can be the first to access the full report from the Lim & Tan Securities website : www.limtan.com.sg

Malaysia Inc. on the Move: Big Contracts, New Deals, and Leadership Shifts

📈 JPMorgan Lifts STI Bull Target to 6,000 on Liquidity Reforms, MAS Initiatives SGX:S27.SI:Straits Times Index US:JPM:JP MorganJP Morgan raised its 12-month bull target for the Straits Times Index (STI) to 6,000 points, up...

Is This the Next Big Thing in Pharma? Hansoh’s Growth Story You Can’t Ignore!

Hansoh Pharma (3692 HK) Investing in Hansoh Pharmaceutical Group Co. Ltd. (3692 HK) presents a compelling opportunity based on several key factors: 1. Robust Financial Performance: Hansoh Pharma has demonstrated strong revenue and earnings...

AirAsia X Surges Ahead: Strong Buying Momentum Fuels Technical Breakout

Report Date: October 24, 2024Broker: CGS International Company Overview AirAsia X Berhad is a Malaysia-based, medium to long-haul, low-cost airline. It is an affiliate of the AirAsia Group and primarily operates flights using Airbus...